Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05424120 · ClinicalTrials.gov registry record · NA

Thoracentesis QI Study

A NA study, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
102
Enrollment target

NCT05424120 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 102 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05424120, a NA study, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target

Study Summary

Researchers will compare 3 standard of care methods of pleural fluid drainage during therapeutic thoracentesis. Patients are randomized to manual aspiration, vacuum bottle drainage or wall suction methods. Primary outcome is procedural time with secondary outcomes of pain and dyspnea scores.

Interventions

  • PROCEDURE Manual aspiration
  • PROCEDURE Wall suction
  • PROCEDURE Vacuum bottle drainage

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2022-01-18
Est. Completion 2023-06-30
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05424120

The ClinicalTrials.gov registry entry for NCT05424120 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Manual aspiration is the first listed.

NCT05424120 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05424120 about?

NCT05424120 is a clinical study titled "Thoracentesis QI Study". Researchers will compare 3 standard of care methods of pleural fluid drainage during therapeutic thoracentesis. Patients are randomized to manual aspiration, vacuum bottle drainage or wall suction methods. Primary outcome is procedural time with secondary outcomes of pain and dyspnea scores.

What is the current status of trial NCT05424120?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2022-01-18. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT05424120?

The interventions under investigation include: Manual aspiration (PROCEDURE), Wall suction (PROCEDURE), Vacuum bottle drainage (PROCEDURE).

Who is sponsoring clinical trial NCT05424120?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.